Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

93 (43%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-02-17 2022-03-24 155155
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95373
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-11-01 95381
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-01-09 2020-02-21 102893
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-11-14 2023-01-12 174595
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-10-22 2020-11-12 126918
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Actual shortage 2024-06-07 2025-03-27 229963
DULOXETINE DR 60MG CAPSULE (DELAYED RELEASE) Resolved 2018-03-16 2018-11-08 43119
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2018-12-04 2019-08-06 68608
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2024-12-20 2025-01-18 246254
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2021-02-05 2021-03-11 133445
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-02-17 2023-04-28 185077
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-06-08 2023-10-03 194144
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-06-20 2023-07-05 195784
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-10-19 2023-11-30 207533
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Resolved 2017-03-13 2020-02-13 1691
EPTIFIBATIDE INJECTION 2MG SOLUTION Resolved 2017-03-13 2020-02-13 1694
ETOPOSIDE INJECTION 20MG LIQUID Resolved 2023-06-20 2023-07-28 195789
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ATORVASTATIN 20MG TABLET Discontinued 2018-10-17 2018-10-17 64612
TEVA-AZITHROMYCIN 250MG TABLET Discontinued 2025-04-25 2025-04-25 255821
TEVA-CARBAMAZEPINE 200MG TABLET Discontinued 2017-06-27 2017-06-27 14052
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
TEVA-CEPHALEXIN 250MG TABLET Discontinued 2020-10-08 2020-10-09 125982
TEVA-CIPROFLOXACIN 500MG TABLET Discontinued 2017-06-27 2017-06-27 14049
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
TEVA-CLARITHROMYCIN 250MG TABLET Discontinued 2020-06-11 2020-06-11 117529
TEVA-CLARITHROMYCIN 500MG TABLET Discontinued 2020-06-11 2020-06-11 117526
TEVA-CLOBETASOL 0.05% LOTION Discontinued 2025-04-25 2025-04-25 255815
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64923
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64926
TEVA-CLONAZEPAM 2MG TABLET Discontinued 2018-10-19 2018-10-19 64929
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Discontinued 2019-10-25 2019-10-26 97248
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Discontinued 2019-10-31 2019-11-01 97589
TEVA-DEFERASIROX 250MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103796

Showing 141 to 160 of 299